Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-26

Clinical Trial Update: Trigeminal Evoked Responses to Improve Rhizotomy [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial is underway to evaluate trigeminal evoked responses to improve rhizotomy for trigeminal neuralgia, with recruitment currently in progress…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Minnesota | Conditions: Trigeminal Neuralgia, Rhizotomy | EARLY_Phase 1 | Status: RECRUITING